Overview of Dr. Boardman
Dr. Alexander Boardman is an oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from UMass Chan Medical School and has been in practice 0 years. He is one of 497 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. He has more than 10 publications and over 500 citings.
Office
530 East 74th Street
New York, NY 10021
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2020 - 2023
Brigham and Women's HospitalResidency, Internal Medicine, 2017 - 2020
University of Massachusetts Medical SchoolClass of 2017
Harvard UniversityBA, Molecular and Cellular Biology, 2007 - 2011
Certifications & Licensure
NJ State Medical License 2023 - 2025
NY State Medical License 2020 - 2025
MA State Medical License 2017 - 2020- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma.Pallawi Torka, Tatyana Feldman, Kerry J Savage, Nivetha Ganesan, Esther Drill
Journal of Clinical Oncology. 2024-12-11 - Predictors and implications of renal injury after CD19 chimeric antigen receptor T-cell therapy.Alexander P Boardman, Victoria Gutgarts, Jessica Flynn, Sean M Devlin, Adam Goldman
Haematologica. 2024-11-21 - Metabolic Tumor Volume Response after Bridging Therapy Determines Chimeric Antigen Receptor T-Cell Outcomes in Large B-Cell Lymphoma.Harper Hubbeling, Doris Leithner, Emily A Silverman, Jessica Flynn, Sean Devlin
Clinical Cancer Research. 2024-11-15
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
